Cargando…

Challenges and insights in immunization in patients with demyelinating diseases: a bench-to-bedside and evidence-based review

BACKGROUND: Infections are among the main causes of death in patients with demyelinating diseases of the central nervous system (CNSDD). Vaccines are effective methods in reducing hospitalization and death from infectious diseases, but they are challenging in patients with CNSDD because of autoimmun...

Descripción completa

Detalles Bibliográficos
Autores principales:	Silva, Guilherme Diogo, de Oliveira, Vítor Falcão, Mendonça, Leonardo Oliveira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academia Brasileira de Neurologia - ABNEURO 2022
Materias:	Inflammatory and Demyelinating Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491426/ https://www.ncbi.nlm.nih.gov/pubmed/35976311 http://dx.doi.org/10.1590/0004-282X-ANP-2022-S121

Ejemplares similares

Differential diagnosis of demyelinating diseases: what's new?
por: Gomes, Ana Beatriz Ayroza Galvão Ribeiro, et al.
Publicado: (2022)

A critical review and update on autoimmune encephalitis: understanding the alphabet soup
por: Simabukuro, Mateus Mistieri, et al.
Publicado: (2022)

How to choose initial treatment in multiple sclerosis patients: a case-based approach
por: Apóstolos, Samira Luisa Pereira, et al.
Publicado: (2022)

Plasma Exchange for Treatment of Refractory Demyelination
por: Cronin, Michael, et al.
Publicado: (2020)

Axonal Damage in Pediatric Multiple Sclerosis
por: Kuntz, Nancy L.
Publicado: (2015)

MRI to Discriminate Pediatric MS from ADEM
por: Rubin, Jennifer P.
Publicado: (2015)

Relation of Posterior Cerebellar Volume to Cognition in MS
por: Millichap, J. Gordon
Publicado: (2015)

Prognostic Factors of MS Conversion in Optic Neuritis
por: Fajardo, Marytery, et al.
Publicado: (2015)

Quality of Life in Multiple Sclerosis
por: Williams, Mitchell T., et al.
Publicado: (2020)

Variables associated with progression of moderate-to-severe Crohn’s disease
por: Sacramento, Carolina da Silva Beda, et al.
Publicado: (2022)

30. AN IMMUNE PATHOGENESIS OF PSYCHOSIS? EVIDENCE AND CHALLENGES FROM BENCH TO BEDSIDE
por: Upthegrove, Rachel
Publicado: (2018)

Ustekinumab in ulcerative colitis‐ insights from the real‐world data
por: Veisman, Ido, et al.
Publicado: (2022)

Does colectomy in UC patients impact on the PSC onset?: A national registry brings new insights
por: Liefferinckx, Claire
Publicado: (2023)

Genital warts and inflammatory bowel diseases: Danish real‐world evidence to assess patient‐relevant outcomes
por: McLellan, Paul, et al.
Publicado: (2022)

Ambulatory care management of 69 patients with acute severe ulcerative colitis in comparison to 695 inpatients: insights from a multicentre UK cohort study
por: Sebastian, Shaji, et al.
Publicado: (2022)

Propionyl-L-Carnitine is Efficacious in Ulcerative Colitis Through its Action on the Immune Function and Microvasculature
por: Scioli, Maria Giovanna, et al.
Publicado: (2014)

Distinct transcriptional signatures in purified circulating immune cells drive heterogeneity in disease location in IBD
por: Verstockt, Bram, et al.
Publicado: (2023)

Clinical procedures used to diagnose inflammatory bowel disease: real-world evidence from a Danish nationwide population-based study
por: Rasmussen, Nathalie Fogh, et al.
Publicado: (2022)

Diverticular Inflammation and Complication Assessment classification, CODA score and fecal calprotectin in clinical assessment of patients with diverticular disease: A decision curve analysis
por: Tursi, Antonio, et al.
Publicado: (2023)

Peripheral blood lymphopenia in sarcoidosis associates with HLA-DRB1 alleles but not with lung immune cells and organ involvement
por: Darlington, Pernilla, et al.
Publicado: (2023)

Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune‐mediated inflammatory diseases: A European retrospective observational study
por: Goessens, Laurent, et al.
Publicado: (2021)

Transmural remission improves clinical outcomes up to 5 years in Crohn's disease
por: Fernandes, Samuel Raimundo, et al.
Publicado: (2022)

Takotsubo Syndrome: From Bench to Bedside and Bedside to Bench
por: Pelliccia, Francesco, et al.
Publicado: (2022)

Bench and Bedside
por: Schmidt, Christian
Publicado: (2002)

CNS Demyelination with TNF-α Blockers
por: Kemanetzoglou, Elissavet, et al.
Publicado: (2017)

Has the therapeutical ceiling been reached in Crohn's disease randomized controlled trials? A systematic review and meta‐analysis
por: Magro, Fernando, et al.
Publicado: (2023)

Hypercapnia in the critically ill: insights from the bench to the bedside
por: Masterson, Claire, et al.
Publicado: (2021)

Editorial: New insights in sarcoidosis: from bench to bedside
por: Cameli, Paolo, et al.
Publicado: (2023)

Sepsis: From Bench to Bedside
por: Silva, Eliézer, et al.
Publicado: (2008)

Editorial: From bench to bedside: the challenge of chronic pain
por: Maiarú, Maria, et al.
Publicado: (2023)

From bench to bedside
por: Verdant, Colin L
Publicado: (2012)

Editorial: Traumatic Brain Injury: From Bench to Bedside
por: Miranda, Aline Silva, et al.
Publicado: (2019)

Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis
por: Kamm, M A, et al.
Publicado: (2008)

Reducing small intestinal permeability attenuates colitis in the IL10 gene-deficient mouse
por: Arrieta, M C, et al.
Publicado: (2008)

Curcumin inhibits VEGF-mediated angiogenesis in human intestinal microvascular endothelial cells through COX-2 and MAPK inhibition
por: Binion, D G, et al.
Publicado: (2008)

SHIP deficiency causes Crohn's disease-like ileitis
por: Kerr, William G, et al.
Publicado: (2010)

Treatment of Relapsing Mild-to-Moderate Ulcerative Colitis With the Probiotic VSL#3 as Adjunctive to a Standard Pharmaceutical Treatment: A Double-Blind, Randomized, Placebo-Controlled Study
por: Tursi, Antonio, et al.
Publicado: (2010)

The Inflammatory Bowel Diseases and Ambient Air Pollution: A Novel Association
por: Kaplan, Gilaad G, et al.
Publicado: (2010)

Adalimumab for the treatment of fistulas in patients with Crohn’s disease
por: Colombel, J-F, et al.
Publicado: (2009)

Neuronal guidance molecule netrin-1 attenuates inflammatory cell trafficking during acute experimental colitis
por: Aherne, Carol M, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_qpifcii7vi7b64dmiolufcb3la